-
Journal of Asthma and Allergy
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Once daily levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria
Review
(4265) Views (1780) Full article downloads
Authors: E Nettis, G F Calogiuri, E Di Leo, F Cardinale, L Macchia, et al
Published Date December 2008
Volume 2009:2 Pages 17 - 23
DOI: http://dx.doi.org/10.2147/JAA.S3022
E Nettis1, G F Calogiuri2, E Di Leo1, F Cardinale3, L Macchia1, A Ferrannini1, A Vacca1,4
1Section of Allergology and Clinical Immunology, Department of Internal Medicine and Infectious Diseases; 24th Pneumology Department, Pneumologic Hospital A Galateo, San Cesario di Lecce, Italy; 3Department of Biomedicina dell’Età Evolutiva, Pediatrics Unit “S Maggiore”; 4Department of Internal Medicine and Clinical Oncology, University of Bari Medical School, Bari, Italy
Abstract: Levocetirizine is the pharmacologically active enantiomer of cetirizine. It is a potent histamine H-1 receptor antagonist with anti-inflammatory and antiallergic properties. The review analyses the levocetirizine’s properties in terms of safety and efficacy both in allergic rhinitis and urticarioid syndromes.
Keywords: allergic rhinitis, chronic idiopatic urticaria, levocetirizine
Readers of this article also read:
Leukotriene receptor antagonists in monotherapy or in combination with antihistamines in the treatment of chronic urticaria: a systematic review
Omalizumab in the management of patients with allergic (IgE-mediated) asthma
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Exacerbation rate, health status and mortality in COPD – a review of potential interventions
Treatment of moderate to severe asthma: patient perspectives on combination inhaler therapy and implications for adherence
Exercise-induced asthma: critical analysis of the protective role of montelukast
Current trends in the treatment of asthma: focus on the simultaneous administration of salmeterol/fluticasone
New therapies and management strategies in the treatment of asthma: patient-focused developments
Prevalence of psychiatric disorders and associated risk factors in women during their postpartum period: a major public health problem and global comparison
- Testimonials
"You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio
- Clinical effectiveness of the Respimat® inhaler device in managing chronic obstructive pulmonary disease: evidence when compared with other handheld inhaler devices
- Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity
- The pathophysiology of bronchiectasis
- Exacerbation rate, health status and mortality in COPD – a review of potential interventions




